Comparison of Immune Reconstitution After Unrelated and Related T-Cell – Depleted Bone Marrow Transplantation : Effect of Patient Age and Donor Leukocyte Infusions

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive cellular immunotherapy for EBV lymphoproliferative disease.

  1997cited by this paper
• HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

  1997cited by this paper
• CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

  1997cited by this paper
• Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation

  1997cited by this paper
• Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome.

  1997cited by this paper
• Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia.

  1997cited by this paper
• Unrelated donor bone marrow transplantation for children with acute leukemia.

  1997cited by this paper
• Molecular histocompatibility typing in unrelated donor bone marrow transplantation.

  1997cited by this paper
• A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.

  1997cited by this paper
• Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.

  1997cited by this paper
• Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission

  1997cited by this paper
• Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts

  1997cited by this paper
• Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery.

  1996cited by this paper
• Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission

  1996cited by this paper
• The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.

  1996cited by this paper
• Immunologic reconstitution following stem cell transplantation

  1996cited by this paper
• Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

  1995cited by this paper
• The effect of thymic function on immunocompetence following bone marrow transplantation.

  1995cited by this paper
• Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome.

  1995cited by this paper
• Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

  1995cited by this paper
• Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles.

  1995cited by this paper
• Unrelated donor marrow transplantation in children.

  1995cited by this paper
• The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.

  1995cited by this paper
• Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.

  1995cited by this paper
• Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

  1995cited by this paper
• The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.

  1995cited by this paper
• Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

  1995cited by this paper
• Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.

  1994cited by this paper
• Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years

  1993cited by this paper
• Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.

  1993cited by this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cited by this paper
• Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

  1993cited by this paper
• Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.

  1993cited by this paper
• An overview of methods for the analysis of longitudinal data.

  1992cited by this paper
• A Standardized Method for Detection of HLA-A and HLA-B Alleles by One-Dimensional Isoelectric Focusing (IEF) Gel Electrophoresis

  1989cited by this paper
• The Use of Time Dependent Covariates in Modelling Data from an Occupational Cohort Study

  1987cited by this paper
• Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

  1986cited by this paper

• Synergistic immune interactions between T cells and natural killer cells in allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: current status and future directions

  2026cites this paper
• All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone

  2025cites this paper
• Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

  2025cites this paper
• Burning Down the House: Thymic Repair and Regeneration After Acute Damage

  2025cites this paper
• Endogenous thymic regeneration: restoring T cell production following injury

  2025cites this paper
• Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

  2025cites this paper
• Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

  2025cites this paper
• The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis

  2025cites this paper
• Within-host viral evolution varies with T cell receptor repertoire diversity independently of viral mutation rates

  2025influential citation
• Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

  2024cites this paper
• Primary and secondary defects of the thymus

  2024cites this paper
• Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation

  2024cites this paper
• Differential analysis of immune reconstitution after allogeneic hematopoietic stem cell transplantation in children with Wiskott-Aldrich syndrome and chronic granulomatous disease

  2023cites this paper
• The frequencies of lymphocyte subsets on "day 30" correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation.

  2023cites this paper
• Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis

  2023cites this paper
• Graft-versus-host disease: teaching old drugs new tricks at less cost

  2023cites this paper
• Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial

  2023cites this paper
• The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases

  2023cites this paper
• T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML

  2023cites this paper
• Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions

  2022cites this paper
• Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.

  2022cites this paper
• Signaling Crosstalks Drive Generation and Regeneration of the Thymus

  2022cites this paper
• Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors’ Repertoire in the Recovery of Systemic Lupus Erythematosus

  2022cites this paper
• miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression

  2022cites this paper
• Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.

  2022cites this paper
• CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT).

  2021cites this paper
• Historical perspective and a glance into the antibody-based conditioning regimens: A new era in the horizon?

  2021cites this paper
• Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses.

  2021cites this paper
• Vaccination Against Diphtheria and Tetanus as a Way to Activate Adaptive Immunity in Children with Solid Tumors

  2021cites this paper
• The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

  2021cites this paper
• Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses

  2021cites this paper
• Human herpes virus 6 DNAemia is associated with worse survival after ex vivo T-cell depleted hematopoietic cell transplant.

  2021cites this paper
• “Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients

  2021cites this paper
• Activation of the Zinc-sensing receptor GPR39 promotes T cell reconstitution after hematopoietic stem cell transplant

  2021cites this paper
• Combined Analysis of Early CD4+ T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching

  2020cites this paper
• T cell regeneration after immunological injury

  2020cites this paper
• Use of the HLA-B leader to optimize cord blood transplantation

  2020cites this paper
• Stem Cell Aging and Regenerative Medicine.

  2020cites this paper
• CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation.

  2020cites this paper
• Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children

  2020cites this paper
• When the Damage Is Done: Injury and Repair in Thymus Function

  2020cites this paper
• Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives

  2020cites this paper
• Standard ATG Dosing Results in Poorer Outcomes in Overexposed Patients after Ex vivo CD34 + Selected Allogeneic Hematopoietic Cell Transplantation

  2020cites this paper
• The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People

  2020cites this paper
• Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantation

  2019cites this paper
• Neutropenic Fever in the Intensive Care Unit

  2019cites this paper
• Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

  2019cites this paper
• Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

  2019cites this paper
• Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.

  2019cites this paper
• Comparison of Immune Reconstitution After Allogeneic Versus Autologous Stem Cell Transplantation in 182 Pediatric Recipients

  2019cites this paper
• Monocyte Reconstitution and Gut Microbiota Composition after Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Janus kinase inhibitor ruxolitinib blocks thymic regeneration after acute thymus injury.

  2019cites this paper
• Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development

  2019cites this paper
• Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation.

  2019cites this paper
• Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.

  2019cites this paper
• Strategies to Improve Posttransplant Immunity

  2019cites this paper
• Principles and Applications of Cellular Therapy in the Setting of Hematopoietic Cell Transplant

  2019cites this paper
• Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation

  2019cites this paper
• Infecciones en el paciente inmunocomprometido (II). Paciente trasplantado

  2018cites this paper
• Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice.

  2018cites this paper
• Genetically enhanced T lymphocytes and the intensive care unit

  2018cites this paper
• Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.

  2018cites this paper
• Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort.

  2018cites this paper
• Characteristic analysis of TCR β-chain CDR3 repertoire for pre- and post-liver transplantation

  2018cites this paper
• Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.

  2018cites this paper
• Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.

  2018cites this paper
• Monitoring the Adaptive Immune System in Septic Shock Patients: Ready for Prime Time?

  2018cites this paper
• Immune reconstitution in cord blood transplantation

  2018cites this paper
• A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression

  2018cites this paper
• A Chemotherapy-only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of Myeloid Malignancies

  2018cites this paper
• Thiamine: An Essential Component of the Metabolic Resuscitation Protocol.

  2018cites this paper
• Advances in ex vivo T cell depletion – where do we stand?

  2018cites this paper
• Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy

  2017cites this paper
• A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers

  2017cites this paper
• Co-infections by double-stranded DNA (dsDNA) viruses after ex vivo T-cell depleted, CD34 + Selected Hematopoietic Cell Transplantation (HCT) and length of readmissions through day

  2017cites this paper
• Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

  2017cites this paper
• Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.

  2017cites this paper
• Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

  2017cites this paper
• Donor Natural Killer Cells and Their Therapeutic Potential in Allogeneic Hematopoietic Stem Cell Transplantation

  2017cites this paper
• The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

  2017cites this paper
• FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.

  2017cites this paper
• Can we make a better match or mismatch with KIR genotyping?

  2016cites this paper
• Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

  2016cites this paper
• Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen–matched or –mismatched donors

  2016cites this paper
• Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution.

  2016cites this paper
• Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment

  2016influential citation
• Matched unrelated donor transplants-State of the art in the 21st century.

  2016cites this paper
• Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

  2016cites this paper
• Modeling Human Leukemia Immunotherapy in Humanized Mice

  2016influential citation
• Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients

  2015cites this paper
• High pre-transplant TREC levels indicate good prognosis after hematopoietic stem cell transplantation

  2015cites this paper
• Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation

  2015cites this paper
• Blood and marrow transplant clinical trials network state of the Science Symposium 2014.

  2015cites this paper
• A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency

  2015cites this paper
• Models to Study NK Cell Biology and Possible Clinical Application

  2015cites this paper
• Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients

  2015influential citation
• Interleukin-22: immunobiology and pathology.

  2015cites this paper
• General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

  2015cites this paper
• Understanding T cell recovery following thymus injury

  2014cites this paper